Global Obesity Management Market Projected to Reach USD 3,494.5 million by 2033, Driven by Increasing Demand for Weight Management Solutions

The global obesity management market is poised for substantial growth, with an expected compound annual growth rate (CAGR) of 5.2% during the forecast period from 2023 to 2033. This upward trajectory is projected to elevate the market value from an estimated USD 2,095.6 million in 2023 to approximately USD 3,494.5 million by 2033.

According to FMI Analysis, effective obesity management services, and solutions are now necessary due to the increased incidence of obesity worldwide. As a result, businesses that focus on the management of obesity are seeing a large increase in demand for their goods and services. Additionally, several businesses or companies involved in the control of obesity are benefiting financially from this trend toward proactive healthcare management.

Market growth is also getting further aided by the firms that have realized the value of including obesity management services in their employee wellness programs. People are being encouraged to seek professional help in controlling their weight and general health due to rising preventative healthcare knowledge and attention. Also, this pattern is noticeable in industrialized areas where obesity and other lifestyle-related illnesses have become serious public health issues.

The stigma associated with obesity and cultural judgments prevents many clients from getting professional treatment or taking part in programs for managing their weight. Also, the high expense of obesity management programs and treatments may discourage some people from using them, especially in low-income areas or emerging economies.

Key Takeaways from the Global Obesity Management Market Study Report by FMI

  • The United States is the leading market in the adoption of obesity management strategies and generated around 32.1% of the global revenue share in 2022. Moreover, market players in the United States are making continuous investments in research and development, working with healthcare practitioners, and taking a patient-centric approach.
  • Germany is the leading market in the Europe region which had a global market share of 29.5% in the year 2022.
  • It is anticipated that demand for obesity management services and solutions in the Asia Pacific region could witness a high CAGR through 2033. For instance, China and India are poised to witness 6.6% and 6.4% CAGRs over the next ten years.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Competitive Landscape for the Obesity Management Market Players

The complexity of obesity and the lack of a universally applicable management strategy are two key barriers even for these leading market players. It is difficult to provide solutions that are universally beneficial since each individual may require a treatment plan that is specialized and unique to them.

In recent years the growing percentage of obese people in third-world countries has encouraged many start-ups to adopt the business of obesity management. However, for such emerging players, it could be essential to make sure obesity control treatments are affordable and accessible to increase their impact.

Key Players Profiled in the Global Market:

  • GlaxoSmithKline Plc.
  • VIVUS, Inc.
  • Novo Nordisk A/S
  • Currax Pharmaceuticals LLC
  • Cheplapharm Arzneimittel GmbH
  • Bausch Health Companies Inc.
  • Takeda Pharmaceuticals, Inc.

Key Segmentation

By Drug Type:

  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide

By Surgery Type:

  • Gastric Bypass Surgery
  • Adjustable Gastric Banding Surgery
  • Gastric Sleeve Surgery
  • Duodenal Switch Surgery
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • E-commerce

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East & Africa (MEA)
  • Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Teleradiology Market Set to Soar to USD 47,748.5 Million by 2034, Driven by Robust 18.3% CAGR

The global teleradiology market is on the brink of remarkable expansion, with projections indicating a surge from USD 8,894.3 million in 2024 to an astounding USD 47,748.5 million by 2034. This growth trajectory, representing a compound annual growth rate (CAGR) of 18.3%, highlights the increasing significance of teleradiology in reshaping healthcare delivery across the globe.

In 2023, the teleradiology sector generated an impressive USD 7,567.5 million, and momentum continues to build with an anticipated growth rate of 17.5% in 2024. Teleradiology, a vital branch of telemedicine, facilitates the transmission of radiological images—including X-rays, CT scans, ultrasounds, and MRIs—enabling real-time interpretation and diagnosis by medical professionals regardless of their geographical location.

This innovative technology bridges the gap between radiologists and patients, ensuring that expert medical opinions are accessible in real time, particularly in emergency situations and rural areas where specialized radiologists may be scarce. By enhancing the speed and accuracy of diagnoses, teleradiology significantly improves patient outcomes and streamlines care delivery.

A key driver behind the success of teleradiology is its robust security measures for transmitting patient data, which guarantees confidentiality and minimizes the risk of data breaches. In today’s healthcare environment, where patient privacy and data security are paramount, this capability is critical.

As the global teleradiology market continues to evolve, it promises to revolutionize diagnostic capabilities and enhance healthcare access, particularly in underserved regions. By providing real-time, expert interpretations of medical images, teleradiology is poised to play a pivotal role in advancing patient care and improving the overall efficiency of healthcare systems worldwide.

Key Takeaways:

  • The global teleradiology market is experiencing significant growth, projected to increase from USD 8,894.3 million in 2024 to USD 47,748.5 million by 2034.
  • This growth is driven by a CAGR of 18.3% during the forecast period, reflecting the increasing importance of teleradiology in healthcare.
  • Germany’s teleradiology market is expected to grow at a CAGR of 18% between 2024 and 2034.
  • The United States holds the largest share of the global teleradiology market and is projected to grow at a CAGR of 4.8% during the forecast period.
  • The Chinese teleradiology market is driven by factors such as increased demand for medical imaging, shortage of radiologists, technological advancements, and government support.

High Demand for Teleradiology: Uncover the Trends and Insights with Our Detailed Report!

Competitive Landscape:

Key players in the teleradiology market are actively investing in the development of advanced and innovative products to enhance reliability and efficiency. Many are also focusing on launching new products to expand their portfolios and strengthen their market presence.

Recent Industry Developments in the Teleradiology Market:

In October 2023, IMAGE Information Systems, in collaboration with Aycan Medical Systems, introduced a new version of the iQ-ROUTER. This medical imaging router is designed to facilitate the transfer of medical images between different healthcare systems.

Additionally, in October 2023, Rology, an AI-assisted teleradiology platform serving the Middle East and Africa, received approval for its platform from the U.S. Food and Drug Administration (FDA).

Key Players of Teleradiology Industry:

  • Cerner Corporation
  • Siemens Healthineers
  • McKesson Corporation
  • Agfa Healthcare
  • MEDNAX Services, Inc.
  • ONRAD Inc.
  • Novarad Corporation
  • TeleDiagnostic Solutions Pvt. Ltd.
  • Teleradiology Solutions
  • Telerad Tech
  • StatRad LLC
  • MedWeb LLC
  • USARAD Holdings, Inc.
  • Everlight Radiology SRL
  • Diagnostics, Vital Radiology Services
  • Telemedicine Clinic

Key Segments of Teleradiology Industry:

By Modality:

In terms of modality, the industry is divided into x-ray scans, CT scans, MRI scans, ultrasound scans, nuclear scan, cardiac echo, mammography and electromyography

By Organ:

In terms of modality, the industry is divided into brain, lung, heart, liver, bones, pancreas, spleen and others

By Region:

Key countries of North America, Latin America, Eastern Europe, Western Europe, East Asia, South Asia & Pacific, and Middle East and Africa (MEA), have been covered in the report.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hospital Capacity Management Solutions Industry in Europe Projected to Reach USD 529.4 Million by 2033

The hospital capacity management solution industry in Europe is set for significant growth, with an anticipated market value of USD 346.4 million in 2023. This sector is projected to expand to USD 529.4 million by 2033, reflecting a robust compound annual growth rate (CAGR) of 4.30% over the next decade.

The growing emphasis on enhancing healthcare efficiency and the rising demand for real-time data analytics and predictive modeling fuels the adoption of advanced capacity management solutions. Furthermore, the integration of the Internet of Things (IoT) and Artificial Intelligence (AI) technologies in healthcare facilities facilitates automated processes, accurate resource allocation, and efficient patient flow management, contributing to the market’s steady growth.

Despite the positive growth trajectory, the market faces certain restraints, including the challenges associated with the integration of complex systems and technologies within existing healthcare infrastructures. Issues related to data privacy and security concerns, coupled with the high initial implementation costs, pose significant hurdles to market expansion. Moreover, the resistance to the adoption of new technologies and the lack of skilled professionals proficient in handling advanced capacity management systems further impedes the market’s growth potential.

Amidst the challenges, the hospital capacity management solutions market in Europe presents lucrative opportunities for companies to capitalize on. The increasing focus on patient-centric care, coupled with the rising adoption of cloud-based healthcare solutions, creates a favorable environment for the development of scalable and cost-effective capacity management systems. Additionally, the surge in government initiatives aimed at modernizing healthcare infrastructures and the growing trend of strategic collaborations between technology firms and healthcare providers open new avenues for introducing innovative and tailored capacity management solutions.

The market is witnessing the emergence of several trends shaping the industry. These trends include the rapid adoption of telehealth services for remote patient monitoring, the integration of blockchain technology for secure data sharing and interoperability, the implementation of predictive analytics and AI-driven decision-making tools for proactive resource planning, and the growing focus on sustainability and green initiatives within healthcare facilities.

“The hospital capacity management solutions industry offers promising opportunities for companies to develop innovative and customizable solutions, foster strategic partnerships with healthcare institutions, and capitalize on the growing demand for advanced technologies to streamline patient care and improve operational workflow.”- Says Lead Analyst.

Key Takeaways from the Europe Hospital Capacity Management Solutions Market:

  • The real-time locating system segment is predicted to hold a significant share of 36.40% in the Europe hospital capacity management solutions industry in 2023.
  • Demand for hospital capacity management solutions in Germany is predicted to expand at a CAGR of 5.50% through 2033.
  • The adoption of hospital capacity management solutions in Italy is anticipated to expand at a 5.0% CAGR through 2033.
  • France’s hospital capacity management solutions industry indicates steady growth of 5.2% through 2033.
  • The hospital capacity management solutions market in the United Kingdom is predicted to develop at a CAGR of 6.10% through 2033.
  • Spain’s hospital capacity management solutions industry is projected to expand at a CAGR of 4.4% through 2033.

Enhanced Market Demand: Discover Thorough Trends and Insights in Our Complete Report!

Competitive Landscape of the Europe Hospital Capacity Management Solutions Market:

The Europe hospital capacity management solutions market is highly competitive, with numerous significant competitors competing for market share. Cerner Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation, TeleTracking Technologies, Inc., and Epic Systems Corporation are the leading players in this market. These companies provide broad and innovative approaches to improve hospital operations, manage patient flow, and increase overall efficiency. Furthermore, smaller enterprises and startups contribute to the competitive landscape by delivering specialist solutions customized to specific hospital needs, increasing market rivalry.

With a strong emphasis on research and development, these companies continually strive to satisfy the changing demands of hospitals in Europe. As the demand for effective hospital capacity management solutions grows, the market is expected to see increased competition and innovation, leading to more advanced and tailored solutions to address the complex challenges hospitals face in effectively managing their capacity.

Recent Developments in the Europe Hospital Capacity Management Solutions Market:

  • Cerner has expanded its presence in the European hospital capacity management market by acquiring MEDHOST, a hospital capacity management solutions provider for small and medium-sized hospitals. The acquisition will allow Cerner to reach a broader range of customers and offer them more comprehensive hospital capacity management solutions.
  • McKesson has entered the European hospital capacity management market by acquiring Cambio Healthcare Systems, a hospital capacity management solutions provider for hospitals of all sizes.

Key Companies Providing Hospital Capacity Management Solutions in Europe:

  • ORBIS
  • CenTrak
  • Allscripts
  • Atos
  • Carestream Health
  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthineers
  • Visure Solutions

Key Segments:

By Product Type:

  • Workflow Management Solutions
  • Asset Management Solutions
  • Bed Management Solutions
  • Quality Patient Care Solutions
  • Real Time Locating System (RTLS)
  • Event Driven Solutions
    • Online Registration Solutions
    • Attendance Management Tools
    • Event Driven Patient Tracking
    • Others

By Application:

  • Standalone Solutions
  • Integrated Solutions

By Country:

  • The United Kingdom
  • Germany
  • France
  • Spain
  • Italy

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Safety Needles Market Set for Unprecedented Growth, Projected to Reach USD 11,972.7 Million by 2033

The global safety needles market is on the brink of remarkable expansion, with market value expected to skyrocket from USD 5,840.7 million in 2023 to an impressive USD 11,972.7 million by 2033. This impressive growth reflects a robust compound annual growth rate (CAGR) of 7.4% over the next decade, driven by an increasing focus on enhanced safety and sustainability in healthcare practices.

Key Drivers of Market Growth

  1. Rising Incidence of Needlestick Injuries

The urgent need for safety needles is propelled by a growing awareness of needlestick injuries. In the United States, over 5.6 million healthcare workers are at risk of such injuries annually, while approximately 1 million incidents are reported each year in the European Union. These statistics underscore the critical importance of safety needles designed to minimize injury risks and protect healthcare professionals.

  1. Increased Prevalence of Chronic and Infectious Diseases

The rising incidence of chronic conditions, particularly diabetes, is significantly fueling market growth. Diabetic patients require frequent insulin injections, driving demand for safety needles that offer reduced discomfort and enhanced safety. Furthermore, the global fight against infectious diseases is also boosting the need for these safer alternatives.

  1. Technological Advancements and Government Support

Innovations in needle technology are enhancing the safety and usability of safety needles. Government initiatives aimed at reducing needlestick injuries and promoting safer healthcare practices are accelerating the global adoption of safety needles. A growing number of companies are entering the market with cutting-edge solutions, further driving this trend.

Challenges and Emerging Trends

Despite the optimistic outlook, the market does face challenges, including improper injection techniques, complications from hemorrhaging, and patient anxiety. Additionally, emerging innovations such as needle-less and alternative drug delivery methods could impact market dynamics.

On a positive note, the industry is increasingly emphasizing sustainability, with manufacturers prioritizing eco-friendly materials in needle production to reduce the environmental impact of medical waste. The home healthcare segment is also emerging as a key growth area, as safety needles become essential for at-home care settings, offering a safer and more convenient option for patients.

As the global healthcare landscape evolves, the safety needles market is poised for further expansion, driven by technological advancements, heightened safety awareness, and a commitment to sustainability.

Regional Insights:

  • North America: Expected to lead the safety needles market during the forecast period, driven by an aging population and high healthcare expenditure.
  • Asia Pacific: The region is anticipated to witness rapid growth, with China showing strong potential to surpass the United States in the future due to its investments in healthcare infrastructure and safety practices.

Safety Needles Market Trends: Discover the Full Details in Our Extensive Report!

Key Market Insights:

  • The United States held a dominant 27.8% share of the global safety needles market in 2022.
  • The UK market is projected to grow at a CAGR of 7.0% through 2033.
  • Japan secured an 8.5% market share in 2022.
  • India is poised for significant progress with an anticipated CAGR of 11.1%.
  • Germany held a notable 7.9% share of the global market.
  • China is expected to experience a swift ascent with a projected CAGR of 9.7%.

Recent Developments:

Noteworthy advancements include Zephyrus Innovations’ Aeroject 3ml safety needle receiving FDA approval in February 2023, and HMD’s introduction of the Single-use Dispojekt Safety Needle in June 2021, designed to enhance protection for healthcare personnel.

Key Companies to Watch:

  • Medtronic Public Limited Company
  • Boston Scientific Corp
  • Becton Dickinson and Company
  • Smith Medical
  • Argon Medical Devices, Inc.
  • Novo Nordisk A/S
  • Terumo Corporation
  • NIPRO Medical Corporation
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Eli Lilly and Company
  • Retractable Technologies

Market Segments:

  • By Product: Fine Aspiring Needles, Biopsy Needles, Hypodermic Needles, Pen Needles, Suture Needles, IV Catheter Needles, Blood Collection Needles, Spinal Anesthesia and Epidural Needles, Prefilled Needles, A.V. Fistula, Cannula Needles, Huber Needles.
  • By Application: Sample Collection, Drug Delivery.
  • By Distribution Channel: Hospitals, Pharmacies, Private Clinics, Retail Pharmacies & Drug Stores, E-commerce.
  • By Region: North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA).

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Asia Pacific Reprocessed Medical Devices Market Poised for Remarkable Growth USD 1,639.4 Million by 2033

The asia pacific reprocessed medical devices market region is set for significant growth over the next decade, with the market’s net worth projected to soar from USD 428.4 million in 2023 to USD 1,639.4 million by 2033. This expansion is expected to occur at an impressive compound annual growth rate (CAGR) of 14.4%, underscoring the sector’s rapid evolution.

As healthcare professionals increasingly adopt sustainable practices, the reprocessing of medical devices is becoming a crucial solution. The strategy of reusing medical equipment is gaining traction in response to the rising concerns over the alarming rate of medical waste. The Asia Pacific region is at the forefront of this transition, where practitioners are embracing the cost-effective and environmentally conscious approach of using reprocessed medical devices without compromising quality or patient safety.

Reprocessed devices help mitigate the impact of escalating medical waste, which poses a severe environmental challenge. In a world that is becoming more aware of the importance of sustainability, the healthcare industry is recognizing the vital role that reprocessed medical devices play in reducing the environmental footprint.

 Top Highlights from the FMI’s Analysis of the Asia Pacific Reprocessed Medical Devices Market: 

  • Japan acquired a 29.4% market share of the Asia Pacific reprocessed medical devices in 2022. The country is projected to account for 11.9% CAGR over the forecast period.
  • China follows Japan as the leader in the Asia Pacific market for reprocessed medical devices in 2022, by acquiring an 18.9% value share in 2022.
  • South East Asia gained a 15.3% value share in 2022. South East Asia is projected to register CAGR of 14.8% in the forecast period.
  • India had the piece of 12.5% market share in the Asia Pacific reprocessed medical devices in the year 2022.
  • Australia had an 11.7% market share in 2022. The country is expected to expand at a CAGR of 14.2% over the upcoming years.
  • New Zealand had a 2.8% value share in 2022. The country is projected to thrive at 12.9% CAGR over the forecast period.
  • China and India are enjoying the most amount of growth in the market, expanding at 18.8% and 18% CAGRs, respectively.
  • Based on devices, cardiology devices gained a market share of 59.2% value share in 2022.
  • Based on the classification, the semi-critical segment acquired 46.17% market share in 2022.
  • Under the reprocessing methods category, third party assisted section gained a 47.51% value share in 2022.
  • Based on end users, the hospitals segment acquired 53.64% market share in 2022.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Innovation Watch: Key Developments in the Market

  • Johnson & Johnson Services, Inc. officially declared that DePuy Synthes got the 510(k) clearance from the United States FDA for ATTUNE Total Knee System in January 2021. This VELYS Robotic-facilitated Solution also has clear indications for use. The sales of the product are projected to increase in the present as well as future to meet the surging demand in the market.
  • Olympus Corporation unveiled that it introduced the OERElite Automatic Endoscope Reprocessor (AER) in October 2020. The product is designed to deploy AcecideC to clean and sterilize up to two endoscopes concurrently in 28 minutes.
  • Cleanpart GmbH launched a quality management system for healthcare devices in April 2020.

Key Players:

  • Stryker Sustainability Solutions, Inc.
  • Medline ReNewal
  • Hygia Health Services, Inc.
  • Cleanpart GmbH
  • ReNu Medical, Inc.
  • SureTek Medical
  • NEScientific
  • Others

Key Segments in Asia Pacific Reprocessed Medical Devices Market are as follows:

By Product Type:

  • Gastroenterology Devices
  • Cardiology Devices
  • Laparoscopy Devices
  • Orthopaedic/Arthroscopic Devices
  • ENT Devices
  • Others
    • Pulse Oximetry Sensors
    • Ultrasound Catheters

By Classification:

  • Critical
  • Semi-critical
  • Non-critical

By Reprocessing Method:

  • In House
  • Third-party Assisted
  • Non-compliant Reprocessors

By End User:

  • Hospitals
  • Diagnostic Centres
  • Ambulatory Surgical Centres

By Country:

  • Australia
  • New Zealand
  • China
  • India
  • South East Asia
  • Japan
  • Rest of Asia Pacific

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Digital Mobile X-Ray Devices Market Poised for Strong Growth, Set to Reach USD 7,272.7 Million by 2033

The global digital mobile X-ray devices market is expected to experience significant growth over the next decade. Valued at USD 3,873.7 million in 2023, the market is projected to expand at a 6.5% annual growth rate (CAGR), reaching a remarkable USD 7,272.7 million by 2033.

This growth is being driven by several key factors, including the increasing prevalence of chronic diseases and a growing aging population globally. As the demand for advanced healthcare solutions rises, digital mobile X-ray devices are becoming an indispensable tool for early and accurate diagnosis.

Market Trends and Key Drivers:

  1. Rising Chronic Disease Incidences: The increasing frequency of chronic illnesses such as cardiovascular disease, diabetes, and respiratory conditions is boosting the demand for diagnostic imaging solutions, including mobile X-ray devices.
  2. Advances in Diagnostic Technology: The introduction of sophisticated diagnostic technologies is enabling faster, clearer, and more accurate imaging. This has become a key factor fueling the market’s expansion.
  3. Increasing Awareness for Early Diagnosis: Patients are more informed about the importance of early detection of chronic conditions, which is leading to higher demand for diagnostic services like mobile X-rays.
  4. Growth of Mobile X-Ray Rental Services: In recent years, organizations offering digital mobile X-ray rental services have emerged, making advanced diagnostic solutions more accessible to hospitals and clinics. This trend is further supported by growing collaborations between healthcare providers and rental service companies, driving new equipment installations.
  5. Technological Benefits of Computed Radiography (CR): Computed radiography offers considerable advantages over traditional systems, including the elimination of consumable costs and a significant reduction in image processing time, making it a preferred choice in many healthcare settings.

Industry Outlook

With the continuous innovation and technological advancements in diagnostic imaging, the digital mobile X-ray devices market is expected to remain at the forefront of healthcare transformation. Hospitals, clinics, and diagnostic centers are increasingly adopting these mobile solutions to offer more flexible and efficient patient care, particularly in remote or underserved areas.

Key Takeaways from the Digital Mobile X-Ray Devices Market Study:

  • The United States leads in sales of digital mobile X-ray devices, accounting for nearly 27.9% of global revenue. North America, including Canada, held a 31.1% global market share in 2022.
  • Germany was the dominant market in Europe, contributing approximately 7.1% to global sales in 2022.
  • In Asia, China is the leading market for digital X-ray device manufacturers, with a projected growth rate of 8.1% CAGR through 2033.
  • The computed radiography (CR) technology segment led the market, accounting for 52.6% of global revenue share in 2022.
  • Mobile devices currently lead the market, representing about 91.1% of total sales in 2022.
  • Sales of X-ray devices for installation in hospitals and medical institutes accounted for nearly 68.7% of total revenue in 2022.

Get the Latest on Digital Mobile X-Ray Devices: Our Full Report Highlights Key Trends and Insights!

Competitive Landscape:

The market is characterized by significant consolidation and competitive activity. Major players are focusing on product development and technological enhancements to stay ahead. Recent developments include:

  • Agfa HealthCare introduced SmartXR for X-ray AI in December 2020, aiming to enhance digital radiography in field hospitals.
  • Canon Medical Systems launched the OMNERA 500A Digital Radiography system in the United States in December 2020, featuring intelligent auto-positioning capabilities.
  • Samsung unveiled the GM85 Fit in April 2022, a new configuration of its premium digital radiography instrument, designed for efficient patient care and FDA-approved.

Key Players in the Digital Mobile X-Ray Devices Market:

  • Canon Inc.
  • Carestream Health
  • General Electric
  • Siemens Healthcare
  • Koninklijke Philips N.V.
  • FUJIFILM Corporation
  • Shimadzu Corporation
  • Ziehm Imaging GmbH
  • MinXray, Inc.

Market Segmentation:

  • By Product: Mobile Devices, Handheld Devices
  • By Technology: Computed Radiography, Direct Radiography
  • By Application: Orthopedic Imaging, Chest Imaging, Dental Imaging, Other Applications
  • By End User: Hospitals, Radiology Centers, Outpatient Clinics, Other End Users
  • By Region: North America, Latin America, Europe, South Asia, East Asia, Oceania, The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Companion Animal Vaccines Market to Reach USD 6.7 Billion by 2033, Driven by Rising Pet Humanization and Awareness of Pet Insurance

Future Market Insights, Inc. has forecasted robust growth in the global companion animal vaccines market, with a projected compound annual growth rate (CAGR) of 6.8% between 2023 and 2033. The market, currently valued at USD 3.4 billion in 2023, is expected to more than double, reaching an estimated USD 6.7 billion by 2033.

Several key factors are fueling this growth, including:

  • Humanization of Pets: As pets are increasingly viewed as family members, owners are prioritizing their health and wellness, driving demand for advanced vaccines.
  • Growing Awareness of Pet Insurance: With more pet owners opting for insurance, preventive healthcare, including vaccinations, has become a significant focus, ensuring pets lead longer, healthier lives.
  • Rising Cases of Animal Diseases: An increase in the number of diseases affecting companion animals has heightened the need for effective vaccines, further propelling the market’s growth.

As companion animals play a growing role in households across the globe, the demand for vaccinations to prevent diseases is expected to remain strong, supporting the sustained expansion of the market in the coming decade.

The passage outlines two main restraining factors for the companion animal vaccines market:

Shift in Sales Channels:

  • The Fairness to Pet Owners Act allows pet owners to purchase vaccines from retailers and pharmacies, bypassing veterinarians.
  • This reduces the market share traditionally held by veterinarians and forces vaccine companies to adapt their sales strategies.
  • The shift might also affect profit margins due to changes in distribution channels and consolidation of veterinary clinics.

Knowledge Gaps in Disease Epidemiology:

  • Lack of understanding about the prevalence and spread of veterinary diseases, particularly in endemic countries, hinders vaccine development.
  • The example of Newcastle Disease in poultry highlights this issue.
  • Rapid mutations and variations in the virus make it difficult to develop effective vaccines, limiting the market potential.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Competition Analysis:

  • Bayer Healthcare
  • Vétoquinol S.A
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Eli Lilly and Company
  • Heska Corp.
  • Merck Animal Health
  • Sanofi
  • Virbac
  • Pfizer

Companion Animal Vaccines Market Segmentation

By Product Type:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

By Distribution Channel:

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies

By Species Types:

  • Canine
  • Avian
  • Feline

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Radial Compression Devices Market Set for Remarkable Growth, Expected to Reach USD 599.9 Million by 2033  

The global radial compression devices market is set to experience impressive growth over the next decade, with market size projected to rise from US$ 255.5 million in 2023 to an estimated US$ 599.9 million by 2033, according to recent market projections. This surge is fueled by a Compound Annual Growth Rate (CAGR) of 8.9%, driven by advancements in interventional cardiology and the growing global burden of cardiovascular diseases (CVD).

Increasing Cardiovascular Disease Burden

Cardiovascular diseases remain the leading cause of mortality worldwide. Despite medical advancements, CVD rates continue to rise, especially in regions outside of high-income countries. Notably, in several high-income regions where CVD had been declining, a reversal of this trend has been observed. According to the American Heart Association, by 2035, more than 130 million adults in the United States are expected to suffer from some form of cardiovascular disease, underscoring the urgent need for improved diagnostic and interventional tools.

Growth Driven by Advances in Radial Artery Access

Radial artery access has become a key technique in modern interventional cardiology for cardiovascular diagnosis and intervention. Its minimally invasive nature offers several benefits, including reduced bleeding complications and faster patient recovery times. The increasing adoption of this technique is directly contributing to the rise in demand for radial compression devices, which are essential in maintaining hemostasis following these procedures.

Investments in Training and Technology

Efforts to expand the use of radial artery compression devices have been bolstered by independent cath labs investing in training for healthcare professionals. Notably, in 2009, the Jesse Brown VA Medical Center in Chicago took the initiative to train staff outside of the cath lab on the usage of these devices, ensuring a wider pool of trained personnel capable of performing these procedures safely.

Moreover, companies operating in this sector are focusing on producing enhanced radial compression devices that offer improved hemostasis while minimizing risks to local nerve structures. These design improvements are expected to drive further adoption and market growth.

Technological Advancements and Future Outlook

The increasing prevalence of cardiovascular disease, particularly among adult populations in industrialized nations, is driving demand for innovative solutions. Interventional cardiologists and radiologists stand to benefit from continuous technological advancements introduced by key players in the healthcare sector. Improved material design and the development of more efficient compression devices are expected to accelerate sales in the coming years.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Key Takeaways from Market Study:

  • Band/strap-based devices had the highest market share of 79.8% in 2021, expanding at a 9.6% CAGR during the forecast period. Band/Strap based radial compression devices are primarily driven by factors such as shorter hospital stays and lower surgical costs.
  • Disposable devices accounted for 92.9% of the market in 2021 and expanding at an impressive rate of 9.0%. Disposable radial compression devices are highly adopted due to its cost effectiveness and reduces the incidence of radial artery occlusion.
  • S. will lead the global market and contribute a revenue share of USD 224.6 Million by 2033. Incorporation of advanced technology and leading industry players in the marketplaces are the major factors behind their dominance.
  • K. witnessed a growth of USD 15.9 Million over last decade and a CAGR of 9.4%. The industry is expanding as a result of increased consumer awareness. Furthermore, government initiatives, an ageing population, and industry leaders all contribute to market growth.
  • China will emerge as the most lucrative region among all growing at a CAGR of 10.0%. Rapid socioeconomic advancement has had a significant impact on Chinese culture. The risk of cardiovascular disorders in the country has increased as a result of lifestyle changes, urbanisation, and an ageing population.

“Increasing use of radial compression devices in percutaneous coronary intervention procedures (PCI), due to rising cardiovascular disorders to drive the demand of radial compression over the Decade,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.

Product launching is the key strategy adopted by the manufacturers:

Companies in the Radial Compression Devices Industry are actively attempting to strengthen their positions through new product launches and approvals by both established and emerging market players. The product launch and acquisition speed up the manufacturer’s strategy to capitalise on market share and capture a sizable market share. Among the most recent examples are:

  • Merit Medical launched PreludeSYNC EVO, a radial compression device, in the United States in August 2019. This sterile, single-use device is used to aid in the Hemostasis of the arterial percutaneous access site following catheterization procedures.
  • Cordis launched the RADIAL 360 portfolio in the United States in May 2019. With this launch, the company provides a full range of products to aid in the transradial approach (TRA) for interventional cardiology.
  • In 2018, TZ Medical Inc. received FDA approval for its Adjustable Radial Cuff (ARC) Hemostasis Devices in the United States.

Some of the leading companies operating in the Radial Compression Devices Industry are:

  • Terumo Corporation
  • Merit Medical Inc.
  • Abbott Laboratories
  • Vascular Solutions
  • ConMed B.V.
  • Cardinal Health
  • Beijing Demax Medical Technology
  • Teleflex Incorporated
  • Forge Medical Inc.
  • TZ Medical Inc
  • Semler Technologies Inc
  • Advanced Vascular Dynamics
  • MedPlus, Inc.
  • Lepu Medical

Radial Compression Devices Industry by Category:

Product Type:

  • Band/Strap based radial compression devices
  • Knob-based radial compression devices
  • Plate-based radial compression devices

Application:

  • Diagnostic intervention
  • Surgical intervention

End User:

  • Hospitals
  • Independent Catheterization Labs
  • Ambulatory Surgery Centers
  • Specialized Centers

By Usage:

  • Disposable
  • Reusable

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Auto-Injectors Market Set for Remarkable Growth, Projected to Reach USD 67,200.1 million by 2033

The global auto-injectors market is on a significant growth trajectory, with market share expected to reach a robust valuation of USD 30,578.2 million in 2023. This figure represents a strong presence in the healthcare industry, but it’s the projected growth over the next decade that is truly captivating industry experts. By 2033, the market is anticipated to surge to an impressive USD 67,200.1 million, marking a compound annual growth rate (CAGR) of 8.2% from 2023 to 2033.

Auto-injectors, which are gaining prominence for their ease of use and efficacy in administering life-saving medications, are becoming indispensable in both clinical and emergency settings. These devices are particularly noted for delivering biologics and critical drugs, ensuring rapid response and improved patient outcomes. From 2018 to 2022, the market exhibited an even higher growth rate, with a CAGR of 11.6%, reflecting the rapid pace at which auto-injectors were adopted globally.

Adoption Surge Fueled by Convenience and Innovation

Auto-injectors have witnessed widespread adoption, particularly due to their ability to simplify drug administration for patients. Devices like EpiPen, Anapen, Jext, and Auvi-Q are now essential for individuals managing severe allergic reactions, providing swift, precise responses during anaphylactic emergencies. This growing reliance on auto-injectors has prompted extensive user training programs, ensuring that patients and caregivers are equipped to use these devices effectively during critical moments.

However, with increased adoption comes the need for heightened awareness. Consumers must be informed about potential side effects and seek appropriate insurance coverage to mitigate the cost variations among different devices. Additionally, autoinjector safety regulations remain paramount, with regulatory bodies closely monitoring safety standards and compliance. In the rare event of device-related issues, autoinjector recalls can occur, pushing users to explore alternative options.

Evolving Market Dynamics and Consumer Preferences

The auto-injector market has also seen significant developments in terms of product accessibility and consumer engagement. With many users actively searching for places to purchase devices or refill prescriptions online, the demand for streamlined, user-friendly platforms is rising. Consumers are not only seeking devices but are also researching and comparing various options, looking into manufacturers’ reviews, and staying updated on advancements in auto-injector research and development.

Meanwhile, clinical trials continue to play a crucial role in ensuring the safety and efficacy of these devices, further influencing regulatory approvals and market adoption.

The Future of Auto-Injectors: Trusted, Accessible, and Life-Saving

As the global auto-injector market grows, the focus remains on patient safety, accessibility, and continuous innovation. With a projected market size of USD 67,200.1 million by 2033, the future looks promising for the auto-injector industry, offering life-saving solutions that cater to the growing demand for effective and efficient drug delivery systems.

The increasing reliance on these devices, coupled with advancements in auto-injector technology, underscores their pivotal role in healthcare, setting the stage for continued growth and innovation in the years to come.

Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!

Key Takeaways from the Auto-Injectors Market:

  • Prefilled auto-injectors dominate the market, commanding an impressive share of 86.30% in 2023.
  • The anaphylaxis indication Segment exhibits remarkable strength, capturing an overwhelming share of 88.7% in 2023.
  • The United States auto-injectors market boasts a substantial share of 29.10% in 2023.
  • Germany established a notable market share of 8.80% in 2023.
  • Japan claims a respectable market share of 1.60% in 2023.
  • Australia secures a significant market share of 5.60% in 2023.
  • China showcases its market prowess with a substantial share of 8.00% in 2023.
  • India also feels its impact with a substantial market share of 8.30% in 2023.

Key Players in the Auto-Injectors Market Striving for Better Revenue Prospects:

The auto-injectors industry boasts a highly competitive landscape with several prominent players vying for market share. Some notable participants include Becton, Dickinson, Company, Sanofi, Pfizer, Inc., Mylan N.V., and Novartis AG. These companies have established their dominance through innovative product offerings and strategic partnerships. Moreover, their extensive global presence enables them to cater to a wide range of therapeutic areas and patient populations.

Another key trend in the competitive landscape is the formation of strategic collaborations between pharmaceutical companies and auto-injector manufacturers. This collaboration results in co-branded devices for specific medications, ensuring precise and user-friendly drug delivery.

This approach has created a win-win situation, with pharmaceutical companies gaining a competitive edge by offering differentiated delivery solutions and auto-injector manufacturers benefiting from increased product demand. As the industry continues to evolve, these partnerships are expected to shape the competitive landscape further, driving innovation and expanding market reach.

Recent Developments in the Market:

  • Stevanato Group Signed an Exclusive Agreement for Aidaptus Auto-Injector: In May 2022, Stevanato Group signed an exclusive agreement with Owen Mumford Ltd. for its Aidaptus auto-injector. The Aidaptus auto-injector is designed for the self-administration of injectable drugs.
  • Antares Pharma Signed an Agreement for XYOSTED in the UAE and Saudi Arabia: In May 2023, Antares Pharma signed an agreement with Lunatus Global Medical Supplies for the distribution of XYOSTED, an autoinjector for the treatment of growth hormone deficiency, in the UAE and Saudi Arabia.
  • SHL Medical Acquires Weibel CDS: In May 2023, SHL Medical acquired Weibel CDS, a Swiss company that develops and manufactures autoinjectors. The acquisition may strengthen SHL Medical’s position in the autoinjector market.
  • Eli Lilly Invests in New Manufacturing Facility for Autoinjectors: In May 2023, Eli Lilly announced an investment of USD 470 million in a new manufacturing facility for autoinjectors in Durham, North Carolina. The new facility is expected to be operational in 2025.
  • Ypsomed Launched a New Autoinjector Platform for Liquid Pharmaceuticals: In October 2022, Ypsomed launched a new autoinjector platform for liquid pharmaceuticals with capacities between 1.5 mL and 5.5 mL. The new platform is designed to be easier and more comfortable for patients.

Key Companies in the Market:

  • Becton, Dickinson, and Company
  • Sanofi
  • Pfizer, Inc
  • Mylan N.V.
  • Novartis AG
  • Bayer AG
  • Janssen Global Services, LLC
  • Antares Pharma, Inc.
  • Amgen Inc
  • Eli Lilly and Company
  • Teva Pharmaceutical
  • Merck KgaA
  • GlaxoSmithKline plc
  • Ypsomed

Key Segments:

By Product:

  • Prefilled Auto-Injectors
  • Fillable Auto-Injectors

By Indication:

  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Surgical Stapling Device Market Set to Reach USD 5,930.60 Million by 2033, Driven by Technological Advancements and Growing Demand for Minimally Invasive Procedures

The global surgical stapling device market is poised for remarkable growth, with projections showing an increase from USD 3,977.40 million in 2023 to USD 5,930.60 million by 2033. This represents a compound annual growth rate (CAGR) of 4.10% over the forecast period, according to the latest market research report.

The anticipated surge in market value is fueled by the rising adoption of surgical stapling devices across a wide range of medical procedures. These devices are proving indispensable in laparoscopic, bariatric, and endoscopic surgeries, which are vital for managing chronic conditions such as obesity, sports-related injuries, and arthritis.

A spokesperson from Future Market Insights (FMI) commented, “The global market for surgical stapling devices is experiencing notable growth due to advancements in surgical techniques and increasing prevalence of chronic diseases. These devices play a pivotal role in ensuring precise and efficient wound closure, thereby enhancing patient outcomes and reducing recovery times.”

Key Drivers of Growth:

  • Technological Innovation: The report highlights the significant impact of technological advancements on the efficacy and safety of surgical stapling procedures. These innovations are improving the precision, speed, and overall success rates of surgeries.
  • Chronic Disease Prevalence: As chronic conditions like obesity and arthritis become more common, the demand for minimally invasive procedures, including those requiring surgical stapling devices, continues to rise.
  • Favorable Reimbursement Policies: Improved healthcare infrastructure and supportive reimbursement policies across various regions are expected to further drive the adoption of surgical stapling devices.

With the market poised for substantial growth, the future of surgical stapling devices will likely be shaped by ongoing innovations in medical technology and an increased focus on minimally invasive surgeries.

Key Takeaways:

  • In 2022, the surgical stapling devices market was valued at USD 3,827.50 Million.
  • Based on product type, the manual segment is expected to account for a share of 87.7% in 2023.
  • Based on usage, disposable segments account for a market share of  4%
  • Global surgical stapling devices demand in China is predicted to account for a CAGR of 5.3% through 2033.
  • Bags in the United States is expected to account for a CAGR of 1.8% between 2023 and 2033.
  • Germany is projected to expand by a value CAGR of 2.5% between 2023 and 2033.
  • By 2033, the surgical stapling devices market in India is anticipated to record a CAGR of 6.2% during the forecast period.

“The high volume of surgical procedures performed and growing aging population, is a major factor accelerating the market growth.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Boosted Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!

Competitive Landscape:

The overall market is highly fragmented, with several competitors in the surgical stapling devices production sphere. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.

  • Medtronic in December 2020, introduced EEA™ Circular Stapler, which has the Tri-Staple™ Technology. It is a first 3-row Circular Stapler having variations in height of staples. The Tri-Staple™ Technology helps reduce the stress on the tissue and consists of a sloped cartridge face.
  • Intuitive Surgical is known for its da Vinci Surgical System, which includes robotic surgical staplers for minimally invasive procedures.
  • Braun Melsungen AG is a global medical device and pharmaceutical company that manufactures surgical stapling devices for various surgical applications.
  • Dextera Surgical focuses on the development of innovative stapling solutions for minimally invasive surgical procedures.

Surgical Stapling Devices Market Segmentation:

By Product:

  • Powered Surgical Stapling Device
  • Manual Surgical Stapling Device

By Usage:

  • Disposable Surgical Stapling Device
  • Reusable Surgical Stapling Device

By Stapling Type:

  • Straight
  • Curved
  • Circular

By Indication:

  • Skin
  • Digestive Tract
  • Blood Vessels
  • Hernia
  • Lung
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube